Annual Report 2025

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2025 93 The United Laboratories International Holdings Limited Annual Report 2025 8. FINANCE COSTS 2025 2024 RMB’000 RMB’000 Interest on borrowings 126,612 74,608 Interest on lease liabilities 651 759 127,263 75,367 Less: amounts capitalised in the cost of qualifying assets (57,533) (40,409) 69,730 34,958 Borrowing costs capitalised during the current year arose on the specific borrowing pool and general borrowing pool. The general borrowing costs have been capitalised at a rate of 2.56% (2024: 3.40%) per annum. 9. IMPAIRMENT LOSSES RECOGNISED (REVERSED) UNDER EXPECTED CREDIT LOSS MODEL, NET 2025 2024 RMB’000 RMB’000 Impairment losses recognised (reversed): – trade receivables 18,661 39,254 – banker’s acceptance bills receivables (38) 19 – other receivables 1,620 5,607 20,243 44,880 Details of impairment assessment are set out in Note 37.